Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. [electronic resource]
- Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 06 2016
- 243-51 p. digital
Publication Type: Journal Article; Review
2146-8427
Antiviral Agents--administration & dosage Drug Administration Schedule Drug Therapy, Combination End Stage Liver Disease--diagnosis Hepacivirus--drug effects Hepatitis C, Chronic--diagnosis Humans Liver Transplantation--adverse effects Recurrence Risk Factors Sustained Virologic Response Time Factors Treatment Outcome Virus Activation--drug effects